Life Sciences Innovation Through the Bayh-Dole Act, With Joe Allen

Innovation in life sciences is crucial for many key industries in
the United States and across the globe. It supports advances in
human biotechnology, pharmaceuticals, health care policy, and
beyond. Such advances would not always have been possible without
the Bayh-Dole Act. Rob and Jackie sat down with Joe Allen, who
served as a professional staffer on the U.S. Senate Judiciary
Committee to former Senator Birch Bayh, to discuss the importance
of the Bayh-Dole Act and the future of life sciences
innovation. 


Related


Stephen Ezell, “The Bayh-Dole Act’s Vital Importance to the
U.S. Life-Sciences Innovation System” (ITIF, March 2019).

 “Preserving Bayh-Dole—the “Inspired” Law That Underpins
U.S. Leadership in Life-Sciences Innovation” (ITIF Event, March
2019).

Stephen Ezell, “How Japan Squandered Its Biopharmaceutical
Competitiveness: A Cautionary Tale” (ITIF, July 2022).